Emergent BioSolutions Stock Price. Everything You Need To Know About The Emergent BioSolutions Stock!
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. The company is headquartered in Gaithersburg, Maryland and currently employs 2,500 full-time employees. The company went IPO on 2006-11-15. Its segments include Products Segment and Services Segment. The Products Segment includes the government-medical countermeasures (MCM) business, which focuses on procurement of MCM products and procured product candidates by domestic and international government customers. The company sells MCM products and procures product candidates to domestic and international non-government organizations and to governments outside of the United States. The company also includes the commercial business, which focuses on sales of NARCAN (naloxone HCI) Nasal Spray and its travelers’ vaccines. The Services Segment consists of contract development and manufacturing (CDMO) services, which includes development services (process and analytical development), drug substance manufacturing and drug product manufacturing (fill/finish).
Emergent BioSolutions Stock Price. Everything You Need To Know About The Emergent BioSolutions Stock! performance
- Employees 2500
- Company HQ Gaithersburg
- Website https://emergentbiosolutions.com/
- EBS Asset Type Common Stock
- EBS Market Capitalization 100.6M
- Earnings Per Share -14.85
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 0.022
Emergent BioSolutions is an exciting stock investment opportunity that retail investors from Malaysia, Thailand, Indonesia, and Vietnam should consider. As a leading biopharmaceutical company, Emergent BioSolutions focuses on providing innovative medical solutions to public health threats and emerging infectious diseases. With a strong track record and expertise in vaccine and antibody production, Emergent BioSolutions is well-positioned to capitalize on the increasing demand for healthcare products worldwide. To invest in Emergent BioSolutions from Malaysia, Thailand, Indonesia, and Vietnam, retail investors can take advantage of the investment platform offered by Zorion. By signing up for an account on Zorion, investors gain access to real US stocks and pre-IPO companies, including Emergent BioSolutions. Zorion provides investment insights and recommendations, helping investors make well-informed decisions about their investments. In addition to the investment platform, Zorion offers extensive resources and educational materials to further enhance investors’ knowledge about Emergent BioSolutions and the biopharmaceutical industry as a whole. By accessing these resources, investors can stay updated on the latest developments, trends, and market insights, empowering them to make informed investment decisions. Investing in Emergent BioSolutions from Malaysia, Thailand, Indonesia, and Vietnam through Zorion gives retail investors the opportunity to benefit from the growth potential of the biopharmaceutical sector. With its commitment to public health and strong market position, Emergent BioSolutions represents an attractive investment option. Start investing in Emergent BioSolutions today through Zorion and secure your position in this potentially lucrative stock.
